What is Brent Kelly's NPI number?

Brent Kelly's National Provider Identifier (NPI) is 1992863765, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Brent Kelly's specialty?

Brent Kelly is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Brent Kelly located?

Brent Kelly's practice location on file with NPPES is 301 University Blvd, Galveston, TX 77555-5302.

What is Brent Kelly's phone number?

The practice phone number listed in the NPPES registry for Brent Kelly is (409) 772-2222.

Does Brent Kelly accept Medicare?

Brent Kelly is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Brent Kelly's NPI active?

Yes — Brent Kelly's NPI (1992863765) is active in the NPPES registry as of the last update on 2024-01-16.

IndividualActiveAccepts Medicare

Brent Kelly, MD

NPI 1992863765 · Dermatology Physician · Galveston, TX

Brent Kelly, MD is a Dermatology Physician provider in Galveston, TX (NPI 1992863765).

Provider details

NPI number: 1992863765
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: L4486 (TX)

Practice location

301 University Blvd

Galveston, TX 77555-5302

Phone: (409) 772-2222

Street-level locationGet directions

More TX providers

Mailing address

301 University Blvd

Galveston, TX 77555-5302

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense L4486 (TX)
Allopathic & Osteopathic Physicians
Dermatopathology Physician207ND0900XLicense L4486 (TX)
Allopathic & Osteopathic Physicians
Internal Medicine Physician207R00000XLicense L4486 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(76/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,119 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	774	$2
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	618	$36
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	239	$64
Destruction of Precancer Skin Growth, 1 Growth17000	173	$51
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	87	$95
Pathology Examination of Tissue Using a Microscope, Moderately Low Complexity88304

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 2 distinct drugs on file.

Drug	Part D claims (2024)
Apremilastbrand: Otezla	13
Ketoconazole	13

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$81 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-12-05
Last updated: 2024-01-16
Certified: 2024-01-16

Frequently asked questions

What is Brent Kelly's NPI number?: Brent Kelly's National Provider Identifier (NPI) is 1992863765, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Brent Kelly's specialty?: Brent Kelly is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Brent Kelly located?: Brent Kelly's practice location on file with NPPES is 301 University Blvd, Galveston, TX 77555-5302.
What is Brent Kelly's phone number?: The practice phone number listed in the NPPES registry for Brent Kelly is (409) 772-2222.
Does Brent Kelly accept Medicare?: Brent Kelly is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Brent Kelly's NPI active?: Yes — Brent Kelly's NPI (1992863765) is active in the NPPES registry as of the last update on 2024-01-16.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	774	$2
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	618	$36
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	239	$64
Destruction of Precancer Skin Growth, 1 Growth17000	173	$51
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	87	$95
Pathology Examination of Tissue Using a Microscope, Moderately Low Complexity88304

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 2 distinct drugs on file.

Drug	Part D claims (2024)
Apremilastbrand: Otezla	13
Ketoconazole	13

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$81 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments